Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02945514 · ClinicalTrials.gov registry record

Providing Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response.

A clinical trial of Healthy Volunteers, sponsored by Mayo Clinic.

Completed
Registry status
327
Enrollment target
1
Study location

NCT02945514: Completed study of Healthy Volunteers, sponsored by Mayo Clinic.

NCT02945514 is a study of Healthy Volunteers that has completed, run by Mayo Clinic. The registered enrollment target is 327 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02945514, a study of Healthy Volunteers, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
327 participants
Enrollment target
1
Study location

Study Summary

Provide personally tailored dietary suggestions to participants based on the Personalized Prediction Engine (patent pending) owned by DayTwo.

Conditions Studied

Interventions

  • OTHER DayTwo machine learning algorithm

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 327 participants
Start Date 2016-09
Est. Completion 2018-02-28
Mayo Clinic

2,844 total trials

What the finished NCT02945514 record still lists

NCT02945514 is an observational study that tracks outcomes without assigning an intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (32% lower).

The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which DayTwo machine learning algorithm is the first listed.

NCT02945514 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02945514 about?

NCT02945514 is a clinical study titled "Providing Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response.". Provide personally tailored dietary suggestions to participants based on the Personalized Prediction Engine (patent pending) owned by DayTwo.

What is the current status of trial NCT02945514?

This trial is currently completed. The enrollment target is 327 participants. The study started on 2016-09. Estimated completion is 2018-02-28.

What conditions does trial NCT02945514 study?

This clinical trial studies the following conditions: Healthy Volunteers.

What interventions are being tested in trial NCT02945514?

The interventions under investigation include: DayTwo machine learning algorithm (OTHER).

Who is sponsoring clinical trial NCT02945514?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02945514 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02945514's enrollment target sits among peer trials

327 35th of 283 higher than 249 of 283 other Healthy Volunteers trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04486378 · 327 participants · Phase 2

    A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

  • NCT06370182 · 327 participants · NA

    Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

  • NCT05156983 · 328 participants · Phase 3

    A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

  • NCT05380401 · 328 participants · NA

    Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02945514, the US trial registry maintained by the National Library of Medicine. NCT02945514 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.